| Serial Number | 98919023 |
| Word Mark | BIOPHARMA DEVELOPMENT AI BY BCG X |
| Filing Date | Monday, December 23, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 22, 2025 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials |
| Pseudo Mark | BIOPHARMA DEVELOPMENT AI BY BOSTON CONSULTING GROUP X |
| Goods and Services | Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials |
| Description of Mark | The mark consists of the stacked words "BIOPHARMA , above "DEVELOPMENT AI", which is, in turn, above "BY BCG X", all to the right of a box design containing a circle and two arcs. |
| NOT AVAILABLE | BIOPHARMA DEVELOPMENT AI |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 23, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Boston Consulting Group, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Party Name | The Boston Consulting Group, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Event Date | Event Description |
| Monday, December 23, 2024 | NEW APPLICATION ENTERED |
| Sunday, January 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, January 12, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, May 9, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 15, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 15, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, May 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 17, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 17, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 17, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 18, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 16, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 22, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 22, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 16, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 20, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 20, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 20, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 20, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |